187 related articles for article (PubMed ID: 2114360)
21. Recombinant N-terminal outer membrane porin (OprF) of Pseudomonas aeruginosa is a promising vaccine candidate against both P. aeruginosa and some strains of Acinetobacter baumannii.
Bahey-El-Din M; Mohamed SA; Sheweita SA; Haroun M; Zaghloul TI
Int J Med Microbiol; 2020 Apr; 310(3):151415. PubMed ID: 32156509
[TBL] [Abstract][Full Text] [Related]
22. Recombinant
Li P; Wang X; Sun X; Cimino J; Guan Z; Sun W
Infect Immun; 2021 Oct; 89(11):e0039621. PubMed ID: 34310892
[TBL] [Abstract][Full Text] [Related]
23. [Obtaining of outer membrane protein I of Pseudomonas aeruginosa and assessment of its antigenic properties].
Gatypova EV; Zlygostev SA; Kaloshin AA; Mikhaĭlova NA
Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):50-3. PubMed ID: 19189463
[TBL] [Abstract][Full Text] [Related]
24. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model.
Elhosary MA; Bahey-El-Din M; AbdelBary A; El Guink N; Aboushleib HM
Microb Pathog; 2019 Jun; 131():181-185. PubMed ID: 30978430
[TBL] [Abstract][Full Text] [Related]
25. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.
Baumann U; Göcke K; Gewecke B; Freihorst J; von Specht BU
Respir Res; 2007 Aug; 8(1):57. PubMed ID: 17683588
[TBL] [Abstract][Full Text] [Related]
26. A hybrid outer membrane protein antigen for vaccination against Pseudomonas aeruginosa.
Gabelsberger J; Knapp B; Bauersachs S; Enz UI; von Specht BU; Domdey H
Behring Inst Mitt; 1997 Feb; (98):302-14. PubMed ID: 9382754
[TBL] [Abstract][Full Text] [Related]
27. [Construction of recombinant Bb(pGEX-OprF-I) vaccine of Pseudomonas aeruginosa and its protection elicited in mice].
Liang C; Li W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jul; 35(7):589-594. PubMed ID: 31537242
[TBL] [Abstract][Full Text] [Related]
28. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous
Liu C; Pan X; Xia B; Chen F; Jin Y; Bai F; Priebe G; Cheng Z; Jin S; Wu W
Front Immunol; 2018; 9():1737. PubMed ID: 30093906
[No Abstract] [Full Text] [Related]
29. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa.
Price BM; Barten Legutki J; Galloway DR; von Specht BU; Gilleland LB; Gilleland HE; Staczek J
FEMS Immunol Med Microbiol; 2002 Jun; 33(2):89-99. PubMed ID: 12052563
[TBL] [Abstract][Full Text] [Related]
31. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
[TBL] [Abstract][Full Text] [Related]
32. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
[TBL] [Abstract][Full Text] [Related]
33. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections.
Tanomand A; Farajnia S; Najar Peerayeh S; Majidi J
Iran Biomed J; 2013; 17(1):1-7. PubMed ID: 23279828
[TBL] [Abstract][Full Text] [Related]
34. Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection.
Li P; Wang X; Sun X; Guan Z; Sun W
mSphere; 2021 Oct; 6(5):e0069921. PubMed ID: 34612675
[TBL] [Abstract][Full Text] [Related]
35. Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.
Cote-Sierra J; Bredan A; Toldos CM; Stijlemans B; Brys L; Cornelis P; Segovia M; de Baetselier P; Revets H
Infect Immun; 2002 Jan; 70(1):240-8. PubMed ID: 11748189
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of an outer membrane vaccine against Pseudomonas aeruginosa infection.
von Specht BU; Strigl G; Ehret W; Brendel W
Infection; 1987; 15(5):408-12. PubMed ID: 3121520
[TBL] [Abstract][Full Text] [Related]
37. Immunogenic efficacy of differently produced recombinant vaccines candidates against Pseudomonas aeruginosa infections.
von Specht BU; Gabelsberger J; Knapp B; Hundt E; Schmidt-Pilger H; Bauernsachs S; Lenz U; Domdey H
J Biotechnol; 2000 Sep; 83(1-2):3-12. PubMed ID: 11000453
[TBL] [Abstract][Full Text] [Related]
38. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
Cui Z; Han D; Sun X; Zhang M; Feng X; Sun C; Gu J; Tong C; Lei L; Han W
Appl Microbiol Biotechnol; 2015 Jan; 99(2):667-80. PubMed ID: 25381907
[TBL] [Abstract][Full Text] [Related]
39. Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
Larbig M; Mansouri E; Freihorst J; Tümmler B; Köhler G; Domdey H; Knapp B; Hungerer KD; Hundt E; Gabelsberger J; von Specht BU
Vaccine; 2001 Mar; 19(17-19):2291-7. PubMed ID: 11257350
[TBL] [Abstract][Full Text] [Related]
40. The Pseudomonas aeruginosa outer membrane protein I vaccine: immunogenicity and safe administration in man.
von Specht BU; Lücking HC; Blum B; Schmitt A; Hungerer KD; Domdey H
Behring Inst Mitt; 1997 Feb; (98):326-37. PubMed ID: 9382756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
